SK Biopharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
Business Segments
The company’s business is organized into several key segments, each…
Analysis
Quality compounder
SK Biopharmaceuticals Co., Ltd. earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is fair. The owner-earnings multiple stands at 17.9×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 5% a year, against analyst forecasts of 15%. The price, in other words, assumes less than the experts do.
Growth is moderate; the safety picture is sturdy. The company scores 20/20 on our value-creation score: strong value creator.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202325
50
2023202420252026
All-time high
80
Mar 2026
All-time low
25
Jan 2023
Average rank
43
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
15
5
1
3
Price/Earnings
44
7
1
1
Price/Book
8
1
1
3
Dividend Yield
1
1
1
1
Value (overall)
4
1
1
1
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.